Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Evizon 40 mg safe and active in stabilizing vision in wet AMD

March 6, 2006

No Comments

NicOx signs new ophthalmology agreement with Pfizer

March 6, 2006

No Comments

Alcon withdraws European submission for Retaane

March 3, 2006

No Comments

Lucentis BLA for wet AMD granted priority review

March 3, 2006

No Comments

Recent patents disclose novel ophthalmic drugs

Feb. 28, 2006

No Comments

DuoTrav eye drops recommended for approval in Europe

Feb. 27, 2006

No Comments

Three-year follow-up shows Retisert improves visual acuity

Feb. 23, 2006

No Comments

Positive preliminary phase IIb results for ecabet sodium in dry eye syndrome

Feb. 23, 2006

No Comments

Santen updates status of ophthalmic programs

Feb. 16, 2006

No Comments

Novartis Ophthalmics to copromote Retisert with Bausch & Lomb

Feb. 14, 2006

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Evizon 40 mg safe and active in stabilizing vision in wet AMD

NicOx signs new ophthalmology agreement with Pfizer

Alcon withdraws European submission for Retaane

Lucentis BLA for wet AMD granted priority review

Recent patents disclose novel ophthalmic drugs

DuoTrav eye drops recommended for approval in Europe

Three-year follow-up shows Retisert improves visual acuity

Positive preliminary phase IIb results for ecabet sodium in dry eye syndrome

Santen updates status of ophthalmic programs

Novartis Ophthalmics to copromote Retisert with Bausch & Lomb

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Ocular RSS

Ocular
RSS